- Growth sector company, Merian Chrysalis (MERI), announced that it had entered into a transaction to partially realise one of its investments in the portfolio; this realisation is expected to raise approximately £20m. This transaction has been undertaken at a valuation that represents a material mark up in the company’s current carrying value of the asset. MERI notes that the details of the transaction remain confidential for now.
- Life-sciences company, Syncona (SYNC), said that Freeline Therapeutics (Freeline) has filed a registration statement relating to a proposed initial public offering in the US of its American Depositary Shares. Click here to read an earlier news story on the potential listing of Freeline.
We also have an update from Fair Oaks Income on its dividend and news of a legislative change benefiting Gore Street Energy Storage.